SEC Tracker
Get the app

Possible new Oragenics shares

OGENDilution

Known so far: no new shares from the prospectus covers read · shelf room about $1.0M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $1.0M
  • One third of float $1.0M ($3.1M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $1.0M on the S-3 of Mar 19, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $3.1M public float stated as of Jun 30, 2025, $1.0M, nothing sold off it in the last 12 months. Sources: S-3/A Mar 19, 2026, effective Mar 20, 2026 · public float, as of Jun 30, 2025.

What could become new Oragenics (OGEN) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (4.5M shares, +9% from 4.1M on Aug 7, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

4.5M

Nov 2024 to Aug 2026: from 407K to 4.5M. Adjusted for the 1-for-30 reverse split by Aug 7, 2025: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.